Jan Albert

Publications
Public outreach and news

Articles

Article: JOURNAL OF INFECTIOUS DISEASES. 2024;230(4):e917-e928
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study.
Simoes MP; Hodcroft EB; Simmonds P; Albert J; Alidjinou EK; Ambert-Balay K; Andrés C; Antón A; Auvray C; Bailly J-L; Baldanti F; Bastings C; Beard S; Berengua C; Berginc N; Bloemen M; Blomqvist S; Bosma F; Böttcher S; Bubba L; Buderus S; Cabrerizo M; Calvo C; Celma C; Ceriotti F; Clark G; Costa I; Coste-Burel M; Couderé K; Cremer J; Del Cuerpo Casas M; Daehne T; de Beer J; de Ceano-Vivas M; De Gascun C; de Rougemont A; Dean J; Dembinski JL; Diedrich S; Diez-Domingo J; Dillner L; Dorenberg DH; Ducancelle A; Dudman S; Dyrdak R; Eis-Huebinger A-M; Falces-Romero I; Farkas A; Feeney S; Fernandez-Garcia MD; Flipse J; Franck KT; Galli C; Garrigue I; Geeraedts F; Georgieva I; Giardina F; Guiomar R; Hauzenberger E; Heikens E; Henquell C; Hober D; Hönemann M; Howson-Wells H; Hruškar Ž; Ikonen N; Imbert B; Jansz AR; Jeannoël M; Jiřincová H; Josset L; Keeren K; Kramer-Lindhout N; Krokstad S; Lazrek M; Le Guillou-Guillemette H; Lefeuvre C; Lind A; Lunar MM; Maier M; Marque-Juillet S; McClure CP; McKenna J; Meijer A; Menasalvas Ruiz A; Mengual-Chuliá B; Midgley S; Mirand A; Molenkamp R; Montes M; Moreno-Docón A; Morley U; Murk J-L; Navascués-Ortega A; Nijhuis R; Nikolaeva-Glomb L; Nordbø SA; Numanovic S; Oggioni M; Oñate Vergara E; Pacaud J; Pacreau ML; Panning M; Pariani E; Pekova L; Pellegrinelli L; Petrovec M; Pietsch C; Pilorge L; Piñeiro L; Piralla A; Poljak M; Prochazka B; Rabella N; Rahamat-Langendoen JC; Rainetova P; Reynders M; Riezebos-Brilman A; Roorda L; Savolainen-Kopra C; Schuffenecker I; Smeets LC; Stoyanova A; Stefic K; Swanink C; Tabain I; Tjhie J; Thouault L; Tumiotto C; Uceda Renteria S; Uršič T; Vallet S; Van Ranst M; Van Wunnik P; Verweij JJ; Vila J; Wintermans B; Wollants E; Wolthers KC; Xavier López-Labrador F; Fischer TK; Harvala H; Benschop KSM
Article: NATURE COMMUNICATIONS. 2023;14(1):2164
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
Yu M; Charles A; Cagigi A; Christ W; osterberg B; Falck-Jones S; Azizmohammadi L; ahlberg E; Falck-Jones R; Svensson J; Nie M; Warnqvist A; Hellgren F; Lenart K; Arcoverde Cerveira R; Ols S; Lindgren G; Lin A; Maecker H; Bell M; Johansson N; Albert J; Sundling C; Czarnewski P; Klingstroem J; Faernert A; Lore K; Smed-Soerensen A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2023;120(12):e2220320120
Functional SARS-CoV-2 cross-reactive CD4⁺ T cells established in early childhood decline with age
Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg K-J; Lund-Johansen F; Aleman S; Bjorkhem-Bergman L; Jenmalm MC; Ljunggren H-G; Buggert M; Karlsson AC
Article: ELIFE. 2023;12:e77345
Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx
Vangeti S; Falck-Jones S; Yu M; Osterberg B; Liu S; Asghar M; Sonden K; Paterson C; Whitley P; Albert J; Johansson N; Farnert A; Smed-Sorensen A
Article: PLOS COMPUTATIONAL BIOLOGY. 2022;18(8):e1009741
Combining biomarker and virus phylogenetic models improves HIV-1 epidemiological source identification
Lundgren E; Romero-Severson E; Albert J; Leitner T
Article: THE LANCET INFECTIOUS DISEASES. 2022;22(6):813-820
Neutralisation sensitivity of the SARS-CoV-2 omicron (B.1.1.529) variant: a cross-sectional study
Sheward DJ; Kim C; Ehling RA; Pankow A; Dopico XC; Dyrdak R; Martin DP; Reddy ST; Dillner J; Hedestam GBK; Albert J; Murrell B
Article: PLOS PATHOGENS. 2022;18(5):e1010515
Evolution, geographic spreading, and demographic distribution of Enterovirus D68
Hodcroft EB; Dyrdak R; Andres C; Egli A; Reist J; de Artola DGM; Alcoba-Florez J; Niesters HGM; Anton A; Poelman R; Reynders M; Wollants E; Neher RA; Albert J
Article: VIRUS EVOLUTION. 2022;8(1):veac022
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load
Zhao L; Wymant C; Blanquart F; Golubchik T; Gall A; Bakker M; Bezemer D; Hall M; Ong SH; Albert J; Bannert N; Fellay J; Grabowski MK; Gunsenheimer-Bartmeyer B; Gunthard HF; Kivela P; Kouyos RD; Laeyendecker O; Meyer L; Porter K; van Sighem A; van der Valk M; Berkhout B; Kellam P; Cornelissen M; Reiss P; Fraser C; Ferretti L
Article: SCIENCE. 2022;375(6580):540-545
A highly virulent variant of HIV-1 circulating in the Netherlands
Wymant C; Bezemer D; Blanquart F; Ferretti L; Gall A; Hall M; Golubchik T; Bakker M; Ong SH; Zhao L; Bonsall D; de Cesare M; MacIntyre-Cockett G; Abeler-Doerner L; Albert J; Bannert N; Fellay J; Grabowski MK; Gunsenheimer-Bartmeyer B; Gunthard HF; Kivela P; Kouyos RD; Laeyendecker O; Meyer L; Porter K; Ristola M; van Sighem A; Ben B; Kellam P; Cornelissen M; Reiss P; Fraser C
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2022;11(3):e1379
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates
Dopico XC; Muschiol S; Grinberg NF; Aleman S; Sheward DJ; Hanke L; Ahl M; Vikstrom L; Forsell M; Coquet JM; McInerney G; Dillner J; Bogdanovic G; Murrell B; Albert J; Wallace C; Hedestam GBK
Article: JCI INSIGHT. 2021;6(22):e151463
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Cagigi A; Yu M; Osterberg B; Svensson J; Falck-Jones S; Vangeti S; Ahlberg E; Azizmohammadi L; Warnqvist A; Falck-Jones R; Gubisch PC; Odemis M; Ghafoor F; Eisele M; Lenart K; Bell M; Johansson N; Albert J; Salde J; Pettie DD; Murphy MP; Carter L; King NP; Ols S; Normark J; Ahlm C; Forsell MN; Farnert A; Lore K; Smed-Sorensen A
Article: EUROSURVEILLANCE. 2021;26(45):2100998
Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021
Benschop KSM; Albert J; Anton A; Andres C; Aranzamendi M; Armannsdottir B; Bailly J-L; Baldanti F; Baldvinsdottir GE; Beard S; Berginc N; Boettcher S; Blomqvist S; Bubba L; Calvo C; Cabrerizo M; Cavallero A; Celma C; Ceriotti F; Costa I; Cottrell S; del Cuerpo M; Dean J; Dembinski JL; Diedrich S; Diez-Domingo J; Dorenberg D; Duizer E; Dyrdak R; Fanti D; Farkas A; Feeney S; Flipse J; De Gascun C; Galli C; Georgieva I; Gifford L; Guiomar R; Hoenemann M; Ikonen N; Jeannoel M; Josset L; Keeren K; Lopez-Labrador FX; Maier M; McKenna J; Meijer A; Mengual-Chulia B; Midgley SE; Mirand A; Montes M; Moore C; Morley U; Murk J-L; Nikolaeva-Glomb L; Numanovic S; Oggioni M; Palminha P; Pariani E; Pellegrinelli L; Piralla A; Pietsch C; Pineiro L; Rabella N; Rainetova P; Renteria SCU; Romero MP; Reynders M; Roorda L; Savolainen-Kopra C; Schuffenecker I; Soynova A; Swanink CM; Ursic T; Verweij JJ; Vila J; Vuorinen T; Simmonds P; Fischer TK; Harvala H
Article: LAKARTIDNINGEN. 2021;118:21113
[Precision diagnostics in clinical microbiology].
G Giske C; Allander T; Fröding I; Ininbergs K; Mölling P; Engstrand L; Albert J
Article: NATURE GEOSCIENCE. 2021;14(9):651-658
Muted multidecadal climate variability in central Europe during cold stadial periods
Sirocko F; Martinez-Garcia A; Mudelsee M; Albert J; Britzius S; Christl M; Diehl D; Diensberg B; Friedrich R; Fuhrmann F; Muscheler R; Hamann Y; Schneider R; Schwibus K; Haug GH
Article: JOURNAL OF INTERNAL MEDICINE. 2021;290(3):666-676
Seropositivity in blood donors and pregnant women during the first year of SARS-CoV-2 transmission in Stockholm, Sweden
Castro Dopico X; Muschiol S; Christian M; Hanke L; Sheward DJ; Grinberg NF; Rorbach J; Bogdanovic G; Mcinerney GM; Allander T; Wallace C; Murrell B; Albert J; Karlsson Hedestam GB
Article: EMERGING INFECTIOUS DISEASES. 2021;27(8):2212-2214
Replication in Human Intestinal Enteroids of Infectious Norovirus from Vomit Samples
Hagbom M; Lin J; Falkeborn T; Serrander L; Albert J; Nordgren J; Sharma S
Article: EMERGING INFECTIOUS DISEASES. 2021;27(6):1616-1626
Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe
Benschop KSM; Broberg EK; Hodcroft E; Schmitz D; Albert J; Baicus A; Bailly J-L; Baldvinsdottir G; Berginc N; Blomqvist S; Bottcher S; Brytting M; Bujaki E; Cabrerizo M; Celma C; Cinek O; Claas ECJ; Cremer J; Dean J; Dembinski JL; Demchyshyna I; Diedrich S; Dudman S; Dunning J; Dyrdak R; Emmanouil M; Farkas A; De Gascun C; Fournier G; Georgieva I; Gonzalez-Sanz R; Van Hooydonk-Elving J; Jaaskelainen AJ; Jancauskaite R; Keeren K; Fischer TK; Krokstad S; Nikolaeva-Glomb L; Novakova L; Midgley SE; Mirand A; Molenkamp R; Morley U; Mossong J; Muralyte S; Murk J-L; Nguyen T; Nordbo SA; Osterback R; Pas S; Pellegrinelli L; Pogka V; Prochazka B; Rainetova P; Van Ranst M; Roorda L; Schuffenecker I; Schuurman R; Stoyanova A; Templeton K; Verweij JJ; Voulgari-Kokota A; Vuorinen T; Wollants E; Wolthers KC; Zakikhany K; Neher R; Harvala H; Simmonds P
Article: JOURNAL OF CLINICAL INVESTIGATION. 2021;131(6):144734
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Falck-Jones S; Vangeti S; Yu M; Falck-Jones R; Cagigi A; Badolati I; Osterberg B; Lautenbach MJ; Ahlberg E; Lin A; Lepzien R; Szurgot I; Lenart K; Hellgren F; Maecker H; Salde J; Albert J; Johansson N; Bell M; Lore K; Farnert A; Smed-Sorensen A
Article: JOURNAL OF CLINICAL VIROLOGY. 2021;136:104754
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020
Dyrdak R; Hodcroft EB; Wahlund M; Neher RA; Albert J
Article: AIDS. 2021;35(2):227-234
High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden
Andersson E; Ambikan A; Brannstrom J; Aralaguppe SG; Yilmaz A; Albert J; Neogi U; Sonnerborg A
Article: CELL. 2020;183(1):158-168.e14
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine T; Perez-Potti A; Rivera-Ballesteros O; Stralin K; Gorin J-B; Olsson A; Llewellyn-Lacey S; Kamal H; Bogdanovic G; Muschiol S; Wullimann DJ; Kammann T; Emgard J; Parrot T; Folkesson E; Rooyackers O; Eriksson LI; Henter J-I; Sonnerborg A; Allander T; Albert J; Nielsen M; Klingstrom J; Gredmark-Russ S; Bjorkstrom NK; Sandberg JK; Price DA; Ljunggren H-G; Aleman S; Buggert M
Article: NATURE COMMUNICATIONS. 2020;11(1):4812
Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR
Smyrlaki I; Ekman M; Lentini A; de Sousa NR; Papanicolaou N; Vondracek M; Aarum J; Safari H; Muradrasoli S; Rothfuchs AG; Albert J; Hoegberg B; Reinius B
Article: PLOS COMPUTATIONAL BIOLOGY. 2020;16(9):e1008122
Inferring transmission heterogeneity using virus genealogies: Estimation and targeted prevention
Zhang Y; Leitner T; Albert J; Britton T
Article: MICROBIOLOGY RESOURCE ANNOUNCEMENTS. 2020;9(35):e00934-e00920
Four SARS-CoV-2 Genome Sequences from Late April in Stockholm, Sweden, Reveal a Rare Mutation in the Spike Protein
Soratto TAT; Darban H; Bjerkner A; Coorens M; Albert J; Allander T; Andersson B
Article: INFECTIOUS DISEASES. 2020;52(6):419-422
Fatal encephalitis associated with coronavirus OC43 in an immunocompromised child
Nilsson A; Edner N; Albert J; Ternhag A
Article: SWISS MEDICAL WEEKLY. 2020;150:w20224
Potential impact of seasonal forcing on a SARS-CoV-2 pandemic
Richard NA; Robert D; Valentin D; Emma HB; Jan A
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2019;48(6):1795-1803
Getting more from heterogeneous HIV-1 surveillance data in a high immigration country: estimation of incidence and undiagnosed population size using multiple biomarkers
Giardina F; Romero-Severson EO; Axelsson M; Svedhem V; Leitner T; Britton T; Albert J
Article: ACS SENSORS. 2019;4(9):2381-2388
Homogeneous Differential Magnetic Assay
Sepehri S; de la Torre TZG; Schneiderman JF; Blomgren J; Jesorka A; Johansson C; Nilsson M; Albert J; Stromme M; Winkler D; Kalaboukhovf A
Article: BIOSENSORS. 2019;9(3):E109-109
Characterization of Binding of Magnetic Nanoparticles to Rolling Circle Amplification Products by Turn-On Magnetic Assay
Sepehri S; Agnarsson B; de la Torre TZG; Schneiderman JE; Blomgren J; Jesorka A; Johansson C; Nilsson M; Albert J; Stromme M; Winkler D; Kalaboukhov A
Article: EUROSURVEILLANCE. 2019;24(14):30-37
Challenges in modelling the proportion of undiagnosed HIV infections in Sweden
Andersson E; Nakagawa F; van Sighem A; Axelsson M; Phillips AN; Sonnerborg A; Alber J
Article: AIDS. 2019;33(2):327-337
Effect of incident hepatitis C infection on CD4⁺ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort
van Santen DK; van der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB; Del Amo J; Meyer L; Bucher HC; Chene G; Hamouda O; Pillay D; Rosinska M; Sabin C; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Lutsar I; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix M-L; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Antoniadou A; Chrysos G; Daikos GL; Katsarou O; Rezza G; Dorrucci M; Monforte AD; Schuitemaker H; Sannes M; Kran A-MB; Rosinska M; Tor J; de Olalla PG; Cayla J; Moreno S; Monge S; del Romero J; Perez-Hoyos S; Sonnerborg A; Gunthard H; Scherrer A; Malyuta R; Murphy G; Johnson A; Phillips A; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker J-P; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Moller C; Rakhmanova A; Rockstroh J; Sandhu M; Dedes N; Fenton K; Pizzuti D; Vitoria M; Faggion S; Frost R; Raben D; Schwimmer C; Scott M
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2161
A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection
Poux C; Dondalska A; Bergenstrahle J; Palsson S; Contreras V; Arasa C; Jarver P; Albert J; Busse DC; LeGrand R; Lundeberg J; Tregoning JS; Spetz A-L
Article: PLOS ONE. 2019;14(5):e0217048
The concordance of the limiting antigen and the Bio-Rad avidity assays in persons from Estonia infected mainly with HIV-1 CRF06_cpx
Huik K; Soodla P; Pauskar M; Owen SM; Luo W; Murphy G; Jogeda E-L; Kallas E; Rajasaar H; Avi R; Masciotra S; Lutsar I; Del Amo J; Meyer L; Bucher HC; Chene G; Hamouda O; Pillay D; Prins M; Rosinska M; Sabin C; Touloumi G; Porter K; Olson A; Cartier A; Fradette L; Walker S; Babiker A; De Luca A; Fisher M; Muga R; Kelleher T; Cooper D; Grey P; Finlayson R; Bloch M; Ramacciotti T; Gelgor L; Smith D; Zangerle R; Gill J; Dabis F; Thiebaut R; Costagliola D; Guiguet M; Vanhems P; Chaix M-L; Ghosn J; Boufassa F; Meixenberger K; Bannert N; Bartmeyer B; Antoniadou A; Chrysos G; Daikos GL; Pantazis N; Katsarou O; Rezza G; Dorrucci M; Monforte AD; Geskus R; van der Helm J; Schuitemaker H; Sannes M; Dyrhol-Riise AM; Kran A-MB; Rosinska M; Tor J; de Olalla PG; Cayla J; del Amo J; Moreno S; Monge S; del Romero J; Perez-Hoyos S; Sonnerborg A; Guenthard H; Scherrer A; Malyuta R; Johnson A; Phillips A; Morrison C; Salata R; Mugerwa R; Chipato T; Price MA; Gilmour J; Kamali A; Karita E; Burns F; Giaquinto C; Grarup J; Kirk O; Bailey H; Anne AV; Panteleev A; Thorne C; Aboulker J-P; Albert J; Asandi S; De Wit S; Reiss P; Gatell J; Karpov I; Ledergerber B; Lundgren J; Moller C; Rakhma-nova A; Rockstroh J; Sandhu M; Dedes N; Fenton K; Pizzuti D; Vitoria M; Faggion S; Frost R; Raben D; Schwimmer C; Scott M
Article: VIRUS EVOLUTION. 2019;5(1):vez007
Intra- and interpatient evolution of enterovirus D68 analyzed by whole-genome deep sequencing
Dyrdak R; Mastafa M; Hodcroft EB; Neher RA; Albert J
Article: CLINICAL CHEMISTRY. 2018;64(12):1704-1712
Padlock Probe Assay for Detection and Subtyping of Seasonal Influenza
Neumann F; Hernandez-Neuta I; Grabbe M; Madaboosi N; Albert J; Nilsson M
Article: JOURNAL OF THE INTERNATIONAL AIDS SOCIETY. 2018;21(7):e25161
Expert consensus statement on the science of HIV in the context of criminal law
Barre-Sinoussi F; Karim SSA; Albert J; Bekker L-G; Beyrer C; Cahn P; Calmy A; Grinsztejn B; Grulich A; Kamarulzaman A; Kumarasamy N; Loutfy MR; El Filali KM; Mboup S; Montaner JSG; Munderi P; Pokrovsky V; Vandamme A-M; Young B; Godfrey-Faussett P
Article: AIDS. 2018;32(7):877-884
Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in Sweden
Andersson E; Nordquist A; Esbjornsson J; Flamholc L; Gisslen M; Hejdeman B; Marrone G; Norrgren H; Svedhem V; Wendahl S; Albert J; Sonnerborg A
Article: VIRUS EVOLUTION. 2018;4(1):vey007
Easy and accurate reconstruction of whole HIV genomes from short-read sequence data with shiver
Wymant C; Blanquart F; Golubchik T; Gall A; Bakker M; Bezemer D; Croucher NJ; Hall M; Hillebregt M; Ong SH; Ratmann O; Albert J; Bannert N; Fellay J; Fransen K; Gourlay A; Grabowski MK; Gunsenheimer-Bartmeyer B; Gunthard HF; Kivela P; Kouyos R; Laeyendecker O; Liitsola K; Meyer L; Porter K; Ristola M; van Sighem A; Berkhout B; Cornelissen M; Kellam P; Reiss P; Fraser C
Article: PLOS COMPUTATIONAL BIOLOGY. 2017;13(10):e1005775
Estimating time of HIV-1 infection from next-generation sequence diversity
Puller V; Neher R; Albert J
Article: PLOS BIOLOGY. 2017;15(6):e2001855
Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe
Blanquart F; Wymant C; Cornelissen M; Gall A; Bakker M; Bezemer D; Hall M; Hillebregt M; Ong SH; Albert J; Bannert N; Fellay J; Fransen K; Gourlay AJ; Grabowski MK; Gunsenheimer-Bartmeyer B; Guenthard HF; Kivela P; Kouyos R; Laeyendecker O; Liitsola K; Meyer L; Porter K; Ristola M; van Sighem A; Vanham G; Berkhout B; Kellam P; Reiss P; Fraser C
Article: JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS. 2017;427:14-18
Sensitive magnetic biodetection using magnetic multi-core nanoparticles and RCA coils
Ahrentorp F; Blomgren J; Jonasson C; Sarwe A; Sepehri S; Eriksson E; Kalaboukhov A; Jesorka A; Winkler D; Schneiderman JF; Nilsson M; Albert J; de la Torre TZG; Stromme M; Johansson C
Article: VIRUS EVOLUTION. 2017;3(Suppl 1):vew036.034
A35 Viral evolution and innate immune responses during acute HIV-1 infection and their association with disease pathogenesis.
Hassan AS; Hare J; Kamini G; Yindom LM; Kamali A; Karita E; Kilemba W; Price MA; Borrow P; Bjorkman P; Albert J; Kaleebu P; Allan S; Fast P; Hunter E; Gilmour J; Ndung'u T; Rowland-Jones S; Sanders EJ; Esbjornsson J
Article: PLOS COMPUTATIONAL BIOLOGY. 2017;13(1):e1005316
Inference of Transmission Network Structure from HIV Phylogenetic Trees
Giardina F; Romero-Severson EO; Albert J; Britton T; Leitner T
Article: JOURNAL OF GENERAL VIROLOGY. 2016;97(12):3225-3231
Molecular epidemiology and the evolution of human coxsackievirus A6
Puenpa J; Vongpunsawad S; Osterback R; Waris M; Eriksson E; Albert J; Midgley S; Fischer TK; Eis-Huebinger AM; Cabrerizo M; Gaunt E; Simmonds P; Poovorawan Y
Article: INFECTION, GENETICS AND EVOLUTION. 2016;46:169-179
The global spread of HIV-1 subtype B epidemic
Magiorkinis G; Angelis K; Mamais I; Katzourakis A; Hatzakis A; Albert J; Lawyer G; Hamouda O; Struck D; Vercauteren J; Wensing A; Alexiev I; Asjo B; Balotta C; Gomes P; Camacho RJ; Coughlan S; Griskevicius A; Grossman Z; Horban A; Kostrikis LG; Lepej SJ; Liitsola K; Linka M; Nielsen C; Otelea D; Paredes R; Poljak M; Puchhammer-Stoekl E; Schmit JC; Sonnerborg A; Stanekova D; Stanojevic M; Stylianou DC; Boucher CAB; Nikolopoulos G; Vasylyeva T; Friedman SR; van de Vijver D; Angarano G; Chaix M-L; de Luca A; Korn K; Loveday C; Soriano V; Yerly S; Zazzi M; Vandamme A-M; Paraskevis D
Article: ELIFE. 2016;5:e18889
Establishment and stability of the latent HIV-1 DNA reservoir
Brodin J; Zanini F; Thebo L; Lanz C; Bratt G; Neher RA; Albert J
Article: RETROVIROLOGY. 2016;13(1):61
Impaired B cells survival upon production of inflammatory cytokines by HIV-1 exposed follicular dendritic cells
Sabri F; Prados A; Munoz-Fernandez R; Lantto R; Fernandez-Rubio P; Nasi A; Amu S; Albert J; Garcia Olivares E; Chiodi F
Article: CLINICAL INFECTIOUS DISEASES. 2016;62(5):655-663
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe
Hofstra LM; Sauvageot N; Albert J; Alexiev I; Garcia F; Struck D; Van de Vijver DAMC; Asjo B; Beshkov D; Coughlan S; Descamps D; Griskevicius A; Hamouda O; Horban A; Van Kasteren M; Kolupajeva T; Kostrikis LG; Liitsola K; Linka M; Mor O; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stoeckl E; Sonnerborg A; Stanekova D; Stanojevic M; Van Laethem K; Zazzi M; Lepej SZ; Boucher CAB; Schmit J-C; Wensing AMJ
Article: EPIDEMIOLOGY. 2016;27(2):247-256
A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
Nakagawa F; van Sighem A; Thiebaut R; Smith C; Ratmann O; Cambiano V; Albert J; Amato-Gauci A; Bezemer D; Campbell C; Commenges D; Donoghoe M; Ford D; Kouyos R; Lodwick R; Lundgren J; Pantazis N; Pharris A; Quinten C; Thorne C; Touloumi G; Delpech V; Phillips A
Article: VIRUS EVOLUTION. 2016;2(1):vew010
HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries
Esbjornsson J; Mild M; Audelin A; Fonager J; Skar H; Jorgensen LB; Liitsola K; Bjorkman P; Bratt G; Gisslen M; Sonnerborg A; Nielsen C; Medstrand P; Albert J
Article: PLOS ONE. 2016;11(7):e0158620
How Much Do We Know about Drug Resistance Due to PrEP Use? Analysis of Experts' Opinion and Its Influence on the Projected Public Health Impact
Dimitrov DT; Boily M-C; Hallett TB; Albert J; Boucher C; Mellors JW; Pillay D; van de Vijver DAMC
Article: PLOS ONE. 2016;11(6):e0157398
Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study
Soderman M; Rhedin S; Tolfvenstam T; Rotzen-Ostlund M; Albert J; Broliden K; Lindblom A
Article: ELIFE. 2015;4:e11282
Population genomics of intrapatient HIV-1 evolution
Zanini F; Brodin J; Thebo L; Lanz C; Bratt G; Albert J; Neher RA
Article: INFECTIOUS DISEASES. 2015;47(10):734-738
Coexistence of two clades of enterovirus D68 in pediatric Swedish patients in the summer and fall of 2014
Dyrdak R; Rotzen-Ostlund M; Samuelson A; Eriksson M; Albert J
Article: JOURNAL OF INFECTIOUS DISEASES. 2015;212(4):596-607
Longitudinal Genetic Characterization Reveals That Cell Proliferation Maintains a Persistent HIV Type 1 DNA Pool During Effective HIV Therapy
von Stockenstrom S; Odevall L; Lee E; Sinclair E; Bacchetti P; Killian M; Epling L; Shao W; Hoh R; Ho T; Faria NR; Lemey P; Albert J; Hunt P; Loeb L; Pilcher C; Poole L; Hatano H; Somsouk M; Douek D; Boritz E; Deeks SG; Hecht FM; Palmer S
Article: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY. 2015;44(3):998-1006
Trends of HIV-1 incidence with credible intervals in Sweden 2002-09 reconstructed using a dynamic model of within-patient IgG growth
Romero-Severson EO; Petrie CL; Ionides E; Albert J; Leitner T
Article: JOURNAL OF INFECTIOUS DISEASES. 2015;211(11):1735-1744
Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia
Angelis K; Albert J; Mamais I; Magiorkinis G; Hatzakis A; Hamouda O; Struck D; Vercauteren J; Wensing AMJ; Alexiev I; Asjo B; Balotta C; Camacho RJ; Coughlan S; Griskevicius A; Grossman Z; Horban A; Kostrikis LG; Lepej S; Liitsola K; Linka M; Nielsen C; Otelea D; Paredes R; Poljak M; Puchhammer-Stockl E; Schmit J-C; Sonnerborg A; Stanekova D; Stanojevic M; Boucher CAB; Kaplan L; Vandamme A-M; Paraskevis D
Article: PLOS MEDICINE. 2015;12(4):e1001810
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis
Rhee S-Y; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; de Wit TR; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CAB; Brumme ZL; Busch MP; Bussmann H; Chaix M-L; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Peng KNG; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Teran G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong H-HM; van de Vijver DAMC; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JPA; Vandamme A-M; Shafer RW
Article: PLOS ONE. 2015;10(3):e0119123
Challenges with Using Primer IDs to Improve Accuracy of Next Generation Sequencing
Brodin J; Hedskog C; Heddini A; Benard E; Neher RA; Mild M; Albert J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(12):862-867
Delayed HIV diagnosis common in Sweden, 2003-2010
Widgren K; Skar H; Berglund T; Kling A-M; Tegnell A; Albert J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(12):825-831
Performance of the Simplexa™ Flu A/B & RSV Direct Kit on respiratory samples collected in saline solution
Svensson MJ; Lind I; Wirgart BZ; Ostlund MR; Albert J
Article: MOLECULAR BIOLOGY AND EVOLUTION (MBE). 2014;31(9):2472-2482
Timing and Order of Transmission Events Is Not Directly Reflected in a Pathogen Phylogeny
Romero-Severson E; Skar H; Bulla I; Albert J; Leitner T
Article: CLINICAL AND VACCINE IMMUNOLOGY. 2014;21(8):1192-1194
Evaluation of Bio-Rad Geenius HIV-1 and-2 Assay as a Confirmatory Assay for Detection of HIV-1 and-2 Antibodies
Hallen AH; Samuelson A; Nordin M; Albert J; Bogdanovic G
Article: BMC INFECTIOUS DISEASES. 2014;14:407
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe
Frentz D; Van de Vijver DAMC; Abecasis AB; Albert J; Hamouda O; Jorgensen LB; Kucherer C; Struck D; Schmit J-C; Vercauteren J; Asjo B; Balotta C; Beshkov D; Camacho RJ; Clotet B; Coughlan S; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis LG; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stockl E; Sonnerborg A; Stanekova D; Stanojevic M; Van Wijngaerden E; Wensing AMJ; Boucher CAB
Article: PLOS ONE. 2014;9(4):e94495
Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group
Frentz D; van de Vijver D; Abecasis A; Albert J; Hamouda O; Jorgensen L; Kucherer C; Struck D; Schmit J-C; Vercauteren J; Asjo B; Balotta C; Bergin C; Beshkov D; Camacho R; Clotet B; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis L; Linka KLM; Nielsen C; Otelea D; Paraskevis D; Paredes R; Poljak M; Puchhammer-Stoeckl E; Sonnerborg A; Stanekova D; Stanojevic M; Vandamme A-M; Boucher C; Wensing A
Article: PLOS ONE. 2014;9(7):e101738
Trends and Predictors of Transmitted Drug Resistance (TDR) and Clusters with TDR in a Local Belgian HIV-1 Epidemic
Pineda-Pena A-C; Schrooten Y; Vinken L; Ferreira F; Li G; Trovao NS; Khouri R; Derdelinckx I; De Munter P; Kuecherer C; Kostrikis LG; Nielsen C; Littsola K; Wensing A; Stanojevic M; Paredes R; Balotta C; Albert J; Boucher C; Gomez-Lopez A; Van Wijngaerden E; Van Ranst M; Vercauteren J; Vandamme A-M; Van Laethem K
Article: PLOS ONE. 2014;9(6):e99390
Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades
Neogi U; Haggblom A; Santacatterina M; Bratt G; Gisslen M; Albert J; Sonnerborg A
Article: INFECTION, GENETICS AND EVOLUTION. 2013;19:369-377
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch
Mild M; Gray RR; Kvist A; Lemey P; Goodenow MM; Fenyo EM; Albert J; Salemi M; Esbjornsson J; Medstrand P
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2013;29(9):1237-1244
Longitudinal Ultradeep Characterization of HIV Type 1 R5 and X4 Subpopulations in Patients Followed from Primary Infection to Coreceptor Switch
Hedskog C; Brodin J; Heddini A; Bratt G; Albert J; Mild M
Article: JOURNAL OF VIROLOGY. 2013;87(13):7463-7470
A Single Early Introduction of HIV-1 Subtype B into Central America Accounts for Most Current Cases
Murillo W; Veras N; Prosperi M; Lorenzana de Rivera I; Paz-Bailey G; Morales-Miranda S; Juarez SI; Yang C; DeVos J; Pablo Marin J; Mild M; Albert J; Salemi M
Article: JOURNAL OF INFECTIOUS DISEASES. 2013;207(Suppl 2):S101-S106
Oral Antiretroviral Drugs as Public Health Tools for HIV Prevention: Global Implications for Adherence, Drug Resistance, and the Success of HIV Treatment Programs
Gupta RK; Wainberg MA; Brun-Vezinet F; Gatell JM; Albert J; Sonnerborg A; Nachega JB
Article: RETROVIROLOGY. 2013;10:36
Limited cross-border infections in patients newly diagnosed with HIV in Europe
Frentz D; Wensing AMJ; Albert J; Paraskevis D; Abecasis AB; Hamouda O; Jorgensen LB; Kuecherer C; Struck D; Schmit J-C; Asjo B; Balotta C; Beshkov D; Camacho RJ; Clotet B; Coughlan S; De Wit S; Griskevicius A; Grossman Z; Horban A; Kolupajeva T; Korn K; Kostrikis LG; Liitsola K; Linka M; Nielsen C; Otelea D; Paredes R; Poljak M; Puchhammer-Stoeckl E; Sonnerborg A; Stanekova D; Stanojevic M; Vandamme A-M; Boucher CAB; Van de Vijver DAMC
Article: RETROVIROLOGY. 2013;10:7
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
Abecasis AB; Wensing AMJ; Paraskevis D; Vercauteren J; Theys K; de Vijver DAMCV; Albert J; Asjo B; Balotta C; Beshkov D; Camacho RJ; Clotet B; De Gascun C; Griskevicius A; Grossman Z; Hamouda O; Horban A; Kolupajeva T; Korn K; Kostrikis LG; Kuecherer C; Liitsola K; Linka M; Nielsen C; Otelea D; Paredes R; Poljak M; Puchhammer-Stoeckl E; Schmit J-C; Sonnerborg A; Stanekova D; Stanojevic M; Struck D; Boucher CAB; Vandamme A-M
Article: PLOS ONE. 2013;8(4):e60906
Towards Estimation of HIV-1 Date of Infection: A Time-Continuous IgG-Model Shows That Seroconversion Does Not Occur at the Midpoint between Negative and Positive Tests
Skar H; Albert J; Leitner T
Article: PLOS ONE. 2013;8(3):e59337
Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997-2011
Bontell I; Haggblom A; Bratt G; Albert J; Sonnerborg A
Article: PLOS ONE. 2013;8(7):e70388
PCR-Induced Transitions Are the Major Source of Error in Cleaned Ultra-Deep Pyrosequencing Data
Brodin J; Mild M; Hedskog C; Sherwood E; Leitner T; Andersson B; Albert J
Article: ANTIVIRAL THERAPY. 2013;18(6):831-836
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network
Pillay D; Albert J; Bertagnolio S; Boucher C; Brun-Vezinet F; Clotet B; Giaquinto C; Perno CF
Article: RETROVIROLOGY. 2012;9:81
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
Theys K; Deforche K; Vercauteren J; Libin P; van de Vijver DAMC; Albert J; Asjo B; Balotta C; Bruckova M; Camacho RJ; Clotet B; Coughlan S; Grossman Z; Hamouda O; Horban A; Korn K; Kostrikis LG; Kucherer C; Nielsen C; Paraskevis D; Poljak M; Puchhammer-Stockl E; Riva C; Ruiz L; Liitsola K; Schmit J-C; Schuurman R; Sonnerborg A; Stanekova D; Stanojevic M; Struck D; Van Laethem K; Wensing AMJ; Boucher CAB; Vandamme A-M
Article: JOURNAL OF MEDICAL VIROLOGY. 2012;84(10):1514-1521
Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America
Murillo W; Lorenzana de Rivera I; Albert J; Guardado ME; Isabel Nieto A; Paz-Bailey G
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2012;28(8):928-932
Phylogenetic Analysis of the Latvian HIV-1 Epidemic
Balode D; Skar H; Mild M; Kolupajeva T; Ferdats A; Rozentale B; Leitner T; Albert J
Article: PLOS ONE. 2012;7(3):e33484
Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010
Karlsson A; Bjoerkman P; Bratt G; Ekvall H; Gisslen M; Soennerborg A; Mild M; Albert J
Article: ANTIVIRAL THERAPY. 2012;17(8):1621-1625
Therapy failure resulting from superinfection by a drug-resistant HIV variant
Pingen M; Nouwen JL; Dinant S; Albert J; Mild M; Brodin J; Simen BB; Walsh S; Kayser M; van der Ende ME; Schutten M; Boucher CAB
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2011;27(10):1055-1059
Short Communication: High Prevalence of Drug Resistance in HIV Type 1-Infected Children Born in Honduras and Belize 2001 to 2004
Parham L; Lorenzana de Rivera I; Murillo W; Naver L; Largaespada N; Albert J; Karlsson AC
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(27):11199-11204
Majority of CD4⁺ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule
Josefsson L; King MS; Makitalo B; Brannstrom J; Shao W; Maldarelli F; Kearney MF; Hu W-S; Chen J; Gaines H; Mellors JW; Albert J; Coffin JM; Palmer SE
Article: PLOS ONE. 2011;6(3):e16986
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.
Campbell MS; Mullins JI; Hughes JP; Celum C; Wong KG; Raugi DN; Sorensen S; Stoddard JN; Zhao H; Deng W; Kahle E; Panteleeff D; Baeten JM; McCutchan FE; Albert J; Leitner T; Wald A; Corey L; Lingappa JR; Partners in Prevention HSV/HIV Transmission Study
Article: PLOS ONE. 2011;6(8):e21747
Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality
Skar H; Gutenkunst RN; Ramsay KW; Alaeus A; Albert J; Leitner T
Article: PLOS ONE. 2011;6(7):e22741
Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation
Mild M; Hedskog C; Jernberg J; Albert J
Article: JOURNAL OF VIROLOGY. 2011;85(1):510-518
Dynamics of Two Separate but Linked HIV-1 CRF01_AE Outbreaks among Injection Drug Users in Stockholm, Sweden, and Helsinki, Finland
Skar H; Axelsson M; Berggren I; Thalme A; Gyllensten K; Liitsola K; Brummer-Korvenkontio H; Kivela P; Spanberg E; Leitner T; Albert J
Article: PLOS ONE. 2011;6(6):e20135
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge
Borggren M; Repits J; Sterjovski J; Uchtenhagen H; Churchill MJ; Karlsson A; Albert J; Achour A; Gorry PR; Fenyo EM; Jansson M
Article: JOURNAL OF MEDICAL VIROLOGY. 2010;82(12):2013-2018
Low Prevalence of Transmitted Drug Resistance Among Newly Diagnosed HIV-1 Patients in Latvia
Balode D; Westman M; Kolupajeva T; Rozentale B; Albert J
Article: JOURNAL OF CLINICAL VIROLOGY. 2010;49(4):239-244
Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras
Murillo W; Paz-Bailey G; Morales S; Monterroso E; Paredes M; Dobbs T; Parekh BS; Albert J; de Rivera IL
Article: JOURNAL OF VIROLOGY. 2010;84(14):7412-7415
HIV-2 Genetic Evolution in Patients with Advanced Disease Is Faster than That in Matched HIV-1 Patients
Skar H; Borrego P; Wallstrom TC; Mild M; Marcelino JM; Barroso H; Taveira N; Leitner T; Albert J
Article: PLOS ONE. 2010;5(7):e11345
Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing
Hedskog C; Mild M; Jernberg J; Sherwood E; Bratt G; Leitner T; Lundeberg J; Andersson B; Albert J
Article: HIV MEDICINE. 2010;11(2):95-103
Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment
Murillo W; de Rivera IL; Parham L; Jovel E; Palou E; Karlsson AC; Albert J
Article: JOURNAL OF GENERAL VIROLOGY. 2010;91(Pt 1):199-207
Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus
Mild M; Simon M; Albert J; Mirazimi A
Article: JOURNAL OF INFECTIOUS DISEASES. 2009;200(10):1503-1508
Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe
Vercauteren J; Wensing AMJ; van de Vijver DAMC; Albert J; Balotta C; Hamouda O; Kuecherer C; Struck D; Schmit J-C; Asjo B; Bruckova M; Camacho RJ; Clotet B; Coughlan S; Grossman Z; Horban A; Korn K; Kostrikis L; Nielsen C; Paraskevis D; Poljak M; Puchhammer-Stoeckl E; Riva C; Ruiz L; Salminen M; Schuurman R; Sonnerborg A; Stanekova D; Stanojevic M; Vandamme A-M; Boucher CAB
Article: CYTOKINE. 2009;46(3):325-331
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections
Nowroozalizadeh S; Mansson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyo EM; Norrgren H; Holmgren B; Jansson M
Article: RETROVIROLOGY. 2009;6:49
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
Paraskevis D; Pybus O; Magiorkinis G; Hatzakis A; Wensing AMJ; de Vijver DAV; Albert J; Angarano G; Asjo B; Balotta C; Boeri E; Camacho R; Chaix M-L; Coughlan S; Costagliola D; De Luca A; de Mendoza C; Derdelinckx I; Grossman Z; Hamouda O; Hoepelman IM; Horban A; Korn K; Kuecherer C; Leitner T; Loveday C; MacRae E; Maljkovic-Berry I; Meyer L; Nielsen C; de Coul ELMO; Ormaasen V; Perrin L; Puchhammer-Stoeckl E; Ruiz L; Salminen MO; Schmit J-C; Schuurman R; Soriano V; Stanczak J; Stanojevic M; Struck D; Van Laethem K; Violin M; Yerly S; Zazzi M; Boucher CA; Vandamme A-M
Article: VIROLOGY. 2008;379(1):125-134
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge
Repits J; Sterjovski J; Badia-Martinez D; Mild M; Gray L; Churchill MJ; Purcell DFJ; Karlsson A; Albert J; Fenyoe EM; Achour A; Gorry PR; Jansson M
Article: INFECTION, GENETICS AND EVOLUTION. 2008;8(5):545-552
Multiple HIV-1 introductions into the Swedish intravenous drug user population
Skar H; Sylvan S; Hansson H-B; Gustavsson O; Boman H; Albert J; Leitner T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2008;46(6):2088-2091
Quality control assessment of human immunodeficiency virus type 2 (HIV-2) viral load quantification assays:: Results from an international collaboration on HIV-2 infection in 2006
Damond F; Benard A; Ruelle J; Alabi A; Kupfer B; Gomes P; Rodes B; Albert J; Boeni J; Garson J; Ferns B; Matheron S; Chene G; Vezinet FB
Article: RETROVIROLOGY. 2008;5:28
Evolution of DC-SIGN use revealed by fitness studies of R5 HIV-I variants emerging during AIDS progression
Borggren M; Repits J; Kuylenstierna C; Sterjovski J; Churchill MJ; Purcell DFJ; Karlsson A; Albert J; Gorry PR; Jansson M
Article: AIDS. 2008;22(5):625-635
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes
Wensing AMJ; Vercauteren J; van de Vijver DA; Albert J; Asjo B; Balotta C; Camacho R; Coughlan S; Grossman Z; Horban A; Kucherer C; Nielsen C; Paraskevis D; Loke WC; Poggensee G; Puchhammer-Stockl E; Riva C; Ruiz L; Schmit J-C; Schuurman R; Salminen M; Sonnerborg A; Stanojevic M; Struck D; Vandamme A-M; Boucher CAB
Article: JOURNAL OF GENERAL VIROLOGY. 2007;88(Pt 5):1526-1531
Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma
Abdel-Hamid M; El-Daly M; Molnegren V; El-Kafrawy S; Abdel-Latif S; Esmat G; Strickland GT; Loffredo C; Albert J; Widell A
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2007;45(5):1565-1571
Development and evaluation of an oligonucleotide ligation assay for detection of drug resistance-associated mutations in the human immunodeficiency virus type 2 pol gene
Jallow S; Kaye S; Schutten M; Brandin E; Albert J; McConkey SJ; Corrah T; Whittle H; Vanham G; Rowland-Jones S; Janssens W
Article: JOURNAL OF VIROLOGY. 2006;80(19):9861-9864
Rapid viral decay in simian immunodeficiency virus-infected macaques receiving quadruple antiretroviral therapy
Brandin E; Thorstensson R; Bonhoeffer S; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2006;22(9):908-911
Antiretroviral therapy does not induce HIV type 1-specific neutralizing activity against autologous HIV type 1 isolates
Devito C; Hejdeman B; Albert J; Broliden K; Hinkula J
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2006;38(2):86-103
Antiretroviral treatment of HIV infection:: Swedish recommendations 2005
Gisslén M; Ahlqvist-Rastad J; Albert J; Blaxhult A; Hamberg AK; Lindbäck S; Sandström E; Uhnoo I; Sönnerborg A
Article: ANTIVIRAL THERAPY. 2006;11(8):1031-1039
HIV-1 transmission cluster with M41L 'singleton' mutation and decreased transmission of resistance in newly diagnosed Swedish homosexual men
Lindstrom A; Ohlis A; Huigen M; Nijhuis M; Berglund T; Bratt G; Sandstrom E; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2005;21(12):1003-1010
Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets
Casper C; Mild M; Jansson M; Karlsson A; Holmberg V; Bratt G; van Paaschen H; Biberfeld P; Björndal Å; Albert J; Popovic M; Fenyö EM
Article: JOURNAL OF GENERAL VIROLOGY. 2005;86(Pt 12):3385-3396
Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation
Shi Y; Brandin E; Vincic E; Jansson MA; Blaxhult A; Gyllensten K; Moberg L; Broström C; Fenyö EM; Albert J
Article: JOURNAL OF GENERAL VIROLOGY. 2005;86(Pt 10):2859-2869
Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency
Repits J; Öberg M; Esbjörnsson J; Medstrand P; Karlsson A; Albert J; Fenyö EM; Jansson M
Article: JOURNAL OF VIROLOGY. 2005;79(17):11151-11160
Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue
Karlsson I; Grivel JC; Chen SS; Karlsson A; Albert J; Fenyö EM; Margolis LB
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2005;21(7):608-610
HIV type 2 dynamics
Brandin E; Broström C; Gille E; Bonhoeffer S; Albert J
Article: JOURNAL OF VIROLOGY. 2004;78(21):11807-11815
Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype
Karlsson I; Antonsson L; Shi Y; Öberg M; Karlsson A; Albert J; Olde B; Owman C; Jansson M; Fenyö EM
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2004;42(10):4788-4795
Pyrosequencing for detection of lamivudine-resistant hepatitis B virus
Lindström A; Odeberg J; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2004;20(7):711-715
Cerebrospinal fluid viral load, virus isolation, and intrathecal immunoactivation in HIV type 2 infection
Arvidson N; Gisslén M; Albert J; Brandin E; Svennerholm B; Fuchs D; Hagberg L
Article: AIDS. 2003;17(18):2561-2569
HIV biological variability unveiled:: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
Article: VIROLOGY. 2003;316(1):116-125
Characterization of novel recombinant HIV-1 genomes using the branching index
Wilbe K; Salminen M; Laukkanen T; McCutchan F; Ray SC; Albert J; Leitner T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2003;41(9):4141-4147
Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae:: Consequences for future characterization
Unemo M; Olcén P; Albert J; Fredlund H
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2003;19(7):543-550
pol gene sequence variation in Swedish HIV-2 patients failing antiretroviral therapy
Brandin E; Lindborg L; Gyllensten K; Broström C; Hagberg L; Gisslen M; Tuvesson B; Blaxhult A; Albert J
Article: JOURNAL OF VIROLOGICAL METHODS. 2003;110(1):73-79
A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients
Yun ZB; Lewensohn-Fuchs I; Ljungman P; Ringholm L; Jonsson J; Alberta J
Article: JOURNAL OF VIROLOGICAL METHODS. 2003;107(1):45-51
A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1
Lindström A; Albert J
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2002;40(10):3741-3749
Molecular epidemiology of Neisseria gonorrhoeae:: sequence analysis of the porβ gene confirms presence of two circulating strains
Unemo M; Olcén P; Berglund T; Albert J; Fredlund H
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2002;18(13):957-967
A new cell line-based neutralization assay for primary HIV type 1 isolates
Shi Y; Albert J; Francis G; Holmes H; Fenyö EM
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2002;18(12):849-856
Identification of two CRF11-cpx genomes and two preliminary representative of a new circulating recombinant form (CRF13-cpx) of HIV type 1 in Cameroon
Wilbe K; Casper C; Albert J; Leitner T
Article: TRANSFUSION. 2002;42(6):780-791
Strategies for diagnosis of HTLV-I and -II
Thorstensson R; Albert J; Andersson S
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2002;18(5):343-352
Coreceptor change appears after immune deficiency is established in children infected with different HIV-1 subtypes
Casper C; Navér L; Clevestig P; Belfrage E; Leitner T; Albert J; Lindgren S; Ottenblad C; Bohlin AB; Fenyö EM; Ehrnst A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2002;18(3):193-200
CCR5 or CXCR4 is required for efficient infection of peripheral blood mononuclear cells by promiscuous human immunodeficiency virus type 2 primary isolates
Mörner A; Björndal Å; Leandersson AC; Albert J; Björling E; Jansson M
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2001;39(11):3915-3919
Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden
Jurstrand M; Falk L; Fredlund H; Lindberg M; Olcén P; Andersson S; Persson K; Albert J; Bäckman A
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2001;17(15):1405-1414
Length variation of glycoprotein 120 V2 region in relation to biological phenotypes and coreceptor usage of primary HIV type 1 isolates
Jansson M; Backström E; Scarlatti G; Björndal Å; Matsuda S; Rossi P; Albert J; Wigzell H
Article: JOURNAL OF VIROLOGY. 2001;75(12):5593-5603
Antigenic variation within the CD4 binding site of human immunodeficiency virus type 1 gp120: Effects on chemokine receptor utilization
Hammond AL; Lewis J; May J; Albert J; Balfe P; McKeating JA
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2001;39(2):464-473
Monitoring resistance to human immunodeficiency virus type 1 protease inhibitors by pyrosequencing
O'Meara D; Wilbe K; Leitner T; Hejdeman B; Albert J; Lundeberg J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2001;17(1):81-85
Epidemiology of HIV in Estonia
Ustina V; Zilmer K; Tammai L; Raukas M; Andersson A; Lilja E; Albert J
Article: ANALYTICAL BIOCHEMISTRY. 2001;288(1):28-38
Quantification of HIV-1 using multiple quantitative polymerase chain reaction standards and bioluminometric detection
Nygren M; Ronaghi M; Nyrén P; Albert J; Lundeberg J
Article: ARCHIVES OF INTERNAL MEDICINE (CHICAGO, ILL. : 1908). 2000;160(21):3286-3293
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa -: Significantly, lower plasma virus set point in HIV-2 infection than in HIV-1 infection
Andersson S; Norrgren H; da Silva Z; Biague A; Bamba S; Kwok S; Christopherson C; Biberfeld G; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2000;16(14):1379-1384
High plasma levels of soluble Fas in HIV type 1-infected subjects are not normalized during highly active antiretroviral therapy
De Milito A; Hejdeman B; Albert J; Aleman S; Sönnerborg A; Zazzi M; Chiodi F
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2000;16(13):1313-1318
Evidence of the existence of a new circulating recombinant form of HIV type 1 subtype A/J in Cameroon
Tscherning-Casper C; Dolcini G; Mauclère P; Fenyö EM; Barré-Sinoussi F; Albert J; Menu E
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 2000;16(13):1281-1294
Monoclonal antibodies to native HIV type 1 reverse transcriptase and their interaction with enzymes from different subtypes
Rytting AS; Åkerblom L; Albert J; Unge T; Björling E; Al-Khalili L; Gronowitz JS; Källander CFR
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2000;44(8):2109-2117
Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues.
Van Vaerenbergh K; Van Laethem K; Albert J; Boucher CA; Clotet B; Floridia M; Gerstoft J; Hejdeman B; Nielsen C; Pannecouque C; Perrin L; Pirillo MF; Ruiz L; Schmit JC; Schneider F; Schoolmeester A; Schuurman R; Stellbrink HJ; Stuyver L; Van Lunzen J; Van Remoortel B; Van Wijngaerden E; Vella S; Witvrouw M; Yerly S; De Clercq E; Destmyer J; Vandamme AM
Article: JOURNAL OF CLINICAL VIROLOGY. 2000;17(1):57-63
Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D
Lyamuya E; Olausson-Hansson E; Albert J; Mhalu F; Biberfeld G
Article: JOURNAL OF VIROLOGY. 2000;74(10):4888-4890
Cross-reactive T-helper responses in patients infected with different subtypes of human immunodeficiency virus type 1
Leandersson AC; Gilljam G; Fredriksson M; Hinkula J; Alaeus A; Lidman K; Albert J; Bratt G; Sandström E; Wahren B
Article: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999). 2000;24(1):1-9
Coreceptor usage of HIV-1 isolates representing different genetic subtypes obtained from pregnant Cameroonian women
Tscherning-Casper C; Vödrös D; Menu E; Aperia K; Fredriksson R; Dolcini G; Chaouat G; Barré-Sinoussi F; Albert J; Fenyö EM
Article: JOURNAL OF VIROLOGY. 2000;74(1):363-370
Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay
Heyndrickx L; Janssens W; Zekeng L; Musonda R; Anagonou S; Van der Auwera G; Coppens S; Vereecken K; De Witte K; Van Rampelbergh R; Kahindo M; Morison L; McCutchan FE; Carr JK; Albert J; Essex M; Goudsmit J; Asjö B; Salminen M; Buvé A; van der Groen G
Article: AIDS. 1999;13(17):2349-2359
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.
Nijhuis M; Schuurman R; de Jong D; Erickson J; Gustchina E; Albert J; Schipper P; Gulnik S; Boucher CA
Article: JOURNAL OF HUMAN VIROLOGY. 1999;2(6):325-338
Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS
Jansson M; Backström E; Björndal Å; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(16):1487-1490
An HIV type 1 subtype A outbreak among injecting drug users in Latvia
Ferdats A; Konicheva V; Dievberna I; Lilja E; Albert J
Article: JOURNAL OF VIROLOGY. 1999;73(11):9673-9678
The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy
Tscherning-Casper C; Papadogiannakis N; Anvret M; Stolpe L; Lindgren S; Bohlin AB; Albert J; Fenyo EM
Article: AIDS. 1999;13(14):1819-1826
Characterization of subtype A HIV-1 from Africa by full genome sequencing
Carr JK; Laukkanen T; Salminen MO; Albert J; Alaeus A; Kim B; Sanders-Buell E; Birx DL; McCutchan FE
Article: VIROLOGY. 1999;262(2):312-320
Molecular characterization of human immunodeficiency virus (HIV)-1 and-2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa
Andersson S; Norrgren H; Dias F; Biberfeld G; Albert J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1999;96(19):10752-10757
The molecular clock of HIV-1 unveiled through analysis of a known transmission history.
Leitner T; Albert J
Article: INTERNATIONAL JOURNAL OF STD AND AIDS. 1999;10(8):514-521
Long-term immunotherapy in HIV infection, combined with short-term antiretroviral treatment
Bratt G; Eriksson LE; Sandström E; Gilljam G; Hinkula J; Albert J; Redfield R; Wahren B
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(10):889-894
Assay of plasma samples representing different HIV-1 genetic subtypes: An evaluation of new versions of the Amplicor HIV-1 monitor assay
Alaeus A; Lilja E; Herman S; Spadoro J; Wang J; Albert J
Article: AIDS. 1999;13(8):901-907
Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
Alaeus A; Lidman K; Björkman A; Giesecke J; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(7):647-653
Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients
Björndal Å; Sönnerborg A; Tscherning C; Albert J; Fenyö EM
Article: JOURNAL OF VIROLOGY. 1999;73(3):2343-2349
Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
Mörner A; Björndal Å; Albert J; Kewalramani VN; Littman DR; Inoue R; Thorstensson R; Fenyö EM; Björling E
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1999;15(3):293-297
Virtually full-length sequences of HIV type 1 subtype J reference strains.
Laukkanen T; Albert J; Liitsola K; Green SD; Carr JK; Leitner T; McCutchan FE; Salminen MO
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998;95(24):14441-14446
Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy.
Nijhuis M; Boucher CA; Schipper P; Leitner T; Schuurman R; Albert J
Article: AIDS. 1998;12(16):2193-2202
Treatment history and baseline viral load, but not viral tropism or CCR-5 genotype, influence prolonged antiviral efficacy of highly active antiretroviral treatment
Bratt G; Karlsson A; Leandersson AC; Albert J; Wahren B; Sandström E
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1998;95(15):8886-8891
Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.
Valentin A; Lu W; Rosati M; Schneider R; Albert J; Karlsson A; Pavlakis GN
Article: VIROLOGY. 1998;247(1):22-31
Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G intersubtype recombinants
Carr JK; Salminen MO; Albert J; Sanders-Buell E; Gotte D; Birx DL; McCutchan FE
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 1998;36(7):1864-1870
Use of multiple competitors for quantification of human immunodeficiency virus type 1 RNA in plasma
Vener T; Nygren M; Andersson A; Uhlén M; Albert J; Lundeberg J
Article: AIDS. 1998;12(7):729-736
MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals
Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1998;17(3):214-219
Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels
Martin C; Albert J; Hansson P; Pehrsson PO; Link H; Sonnerborg A
Article: VIROLOGY. 1998;241(2):181-188
Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
Tscherning C; Alaeus A; Fredriksson R; Björndal Å; Deng HK; Littman DR; Fenyö EM; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1998;14(2):157-162
Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates
Palmer S; Alaeus A; Albert J; Cox S
Article: AIDS. 1997;11(14):1709-1717
Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants
Halapi E; Leitner T; Jansson M; Scarlatti G; Orlandi P; Plebani A; Romiti L; Albert J; Wigzell H; Rossi P
Article: AIDS. 1997;11(12):1415-1419
The influence of MT-2 tropism on the prognostic implications of the Delta 32 deletion in the CCR-5 gene
Bratt G; Sandstrom E; Albert J; Samson M; Wahren B
Article: JOURNAL OF VIROLOGY. 1997;71(10):7478-7487
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
Bjorndal A; Deng HK; Jansson M; Fiore JR; Colognesi C; Karlsson A; Albert J; Scarlatti G; Littman DR; Fenyo EM
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1997;16(1):31-38
HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau
Norrgren H; Marquina S; Leitner T; Aaby P; Melbye M; Poulsen AG; Larsen O; Dias F; Escanilla D; Andersson S; Albert J; Naucler A
Article: THE LANCET. 1997;350(9077):562
Differential transmission of HIV-1 and HIV-2.
Christiansen CB; Albert J; Machuca R; Nielsen C
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1997;15(5):381-386
Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994
Krook A; Albert J; Andersson S; Biberfeld G; Blomberg J; Eklund I; Engstrom A; Julander I; Kall K; Martin C; Stendahl P; Struve J; Sonnerborg A
Article: INTERNATIONAL JOURNAL OF STD AND AIDS. 1997;8(8):522-525
Two cases of oral-to-genital HIV-1 transmission.
Bratt GA; Berglund T; Glantzberg BL; Albert J; Sandström E
Article: AIDS. 1997;11(7):859-865
Subtype-specific problems with quantification of plasma HIV-1 RNA
Alaeus A; Lidman K; Sonnerborg A; Albert J
Article: JOURNAL OF VIROLOGY. 1997;71(6):4761-4770
Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history
Leitner T; Kumar S; Albert J
Article: MOLECULAR MEDICINE. 1997;3(2):96-110
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic fab intrabodies against the matrix protein, p17
Levin R; Mhashilkar AM; Dorfman T; Bukovsky A; Zani G; Bagley J; Hinkula J; Niedrig M; Albert J; Wahren B; Gottlinger HG; Marasco WA
Article: AIDS. 1997;11(2):199-202
Most HIV-1 genetic subtypes have entered Sweden
Alaeus A; Leitner T; Lidman K; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1997;13(1):79-85
CD8(+) T cells from HIV type 1-seronegative individuals suppress virus replication in acutely infected cells
Rosok B; Voltersvik P; Larsson BM; Albert J; Brinchmann JE; Asjo B
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 1997;35(1):278-280
Comparison of in-house and commercial sample preparation and PCR amplification systems for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults
Lyamuya E; BredbergRaden U; Albert J; Grankvist O; Msangi V; Kagoma C; Mhalu F; Biberfeld G
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996;93(26):15382-15387
Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates
Jansson M; Popovic M; Karlsson A; Cocchi F; Rossi P; Albert J; Wigzell H
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1996;12(17):1651-1654
Coexistence of subtypes B, F, and a B/F env recombinant of HIV type 1 in Buenos Aires, Argentina
Marquina S; Leitner T; Rabinovich RD; Benetucci J; Libonatti O; Albert J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1996;12(17):1595-1603
Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variants
Leitner T; Korovina G; Marquina S; Smolskaya T; Albert J
Article: JOURNAL OF VIROLOGY. 1996;70(11):7827-7832
Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype
Weber J; Fenyo EM; Beddows S; Kaleebu P; Bjorndal A; Osmanov S; Heyward W; Esparza J; GalvaoCastro B; vandePerre P; Karita E; Wasi C; Sempala S; Tugume B; Biryahwaho B; RubsamenWaigmann H; vonBriesen H; Esser R; Grez M; Holmes H; Newberry A; Ranjbar S; Tomlinson P; Bradac J; McCutchan F; Louwagie J; Hegerich P; LopezGalindez C; Olivares I; Dopazo J; Mullins JI; Delwart EL; Bachmann HM; Goudsmit J; deWolf F; Hahn BH; Gao F; Yue L; Saragosti S; Schochetman G; Kalish M; Luo CC; George R; Pau CP; CheingsongPopov R; Nara P; Albert J; Myers G; Korber B
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996;93(20):10864-10869
Accurate reconstruction of a known HIV-1 transmission history by phylogenetic tree analysis
Leitner T; Escanilla D; Franzen C; Uhlen M; Albert J
Article: BIOTECHNIQUES. 1996;21(2):248-255
Quantification of HIV-1 using multiple competitors in a single-tube assay.
Vener T; Axelsson M; Albert J; Uhlén M; Lundeberg J
Article: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1996;12(9):821-828
Biological phenotype of HIV type 2 isolates correlates with V3 genotype
Albert J; Stalhandske P; Marquina S; Karis J; Fouchier RAM; Norrby E; Chiodi F
Article: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES. 1996;11(1):1-9
SIV infection of monkey spleen cells including follicular dendritic cells in different stages of disease
Stahmer I; Ordonez C; Popovic M; Mesquita R; Ekman M; Albert J; Putkonen P; Bottiger D; Biberfeld G; Biberfeld P
Article: NATURE MEDICINE. 1995;1(9):914-918
LONG-TERM PROTECTION AGAINST SIV-INDUCED DISEASE IN MACAQUES VACCINATED WITH A LIVE ATTENUATED HIV-2 VACCINE
PUTKONEN P; WALTHER L; ZHANG YJ; LI SL; NILSSON C; ALBERT J; BIBERFELD P; THORSTENSSON R; BIBERFELD G
Article: VIROLOGY. 1995;209(1):136-146
BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF SUBTYPE-D, SUBTYPE-G, AND SUBTYPE-A/D RECOMBINANT HIV-1 TRANSMISSIONS IN SWEDEN
LEITNER T; ESCANILLA D; MARQUINA S; WAHLBERG J; BROSTROM C; HANSSON HB; UHLEN M; ALBERT J
Show more

All other publications

Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(11):e462-e463
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses
Sheward DJ; Yang Y; Westerberg M; Oling S; Muschiol S; Sato K; Peacock TP; Hedestam GBK; Albert J; Murrell B
Review: THE LANCET MICROBE. 2023;4(2):e102-e112
Inferring the multiplicity of founder variants initiating HIV-1 infection: a systematic review and individual patient data meta-analysis
Baxter J; Langhorne S; Shi T; Tully DC; Villabona-Arenas CJ; Hue S; Albert J; Brown AL; Atkins KE
Letter: THE LANCET INFECTIOUS DISEASES. 2022;22(11):1538-1540
Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Sheward DJ; Kim C; Fischbach J; Sato K; Muschiol S; Ehling RA; Bjorkstrom NK; Hedestam GBK; Reddy ST; Albert J; Peacock TP; Murrell B
Letter: THE LANCET INFECTIOUS DISEASES. 2022;22(10):1421-1422
Evasion of neutralising antibodies by omicron sublineage BA.2.75
Sheward DJ; Kim C; Fischbach J; Muschiol S; Ehling RA; Bjorkstrom NK; Hedestam GBK; Reddy ST; Albert J; Peacock TP; Murrell B
Review: INFECTIOUS DISEASES. 2021;53(1):1-8
Contagiousness in treated HIV-1 infection
Eriksen J; Albert J; Axelsson M; Berglund T; Brannstrom J; Gaines H; Gisslen M; Groon P; Hagstam P; Naver L; Pettersson K; Stenkvist J; Sonnerborg A; Tegnell A
Letter: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(23):12522-12523
Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable
Mavian C; Pond SK; Marini S; Magalis BR; Vandamme A-M; Dellicour S; Scarpino SV; Houldcroft C; Villabona-Arenas J; Paisie TK; Trovao NS; Boucher C; Zhang Y; Scheuermann RH; Gascuel O; Lam TT-Y; Suchard MA; Abecasis A; Wilkinson E; de Oliveira T; Bento AI; Schmidt HA; Martin D; Hadfield J; Faria N; Grubaugh ND; Neher RA; Baele G; Lemey P; Stadler T; Albert J; Crandall KA; Leitner T; Stamatakis A; Prosperi M; Salemi M
Review: INFECTIOUS DISEASES. 2020;52(5):295-329
Antiretroviral treatment for HIV infection: Swedish recommendations 2019
Eriksen J; Carlander C; Albert J; Flamholc L; Gisslen M; Naver L; Svedhem V; Yilmaz A; Sonnerborg A
Review: INFECTIOUS DISEASES. 2018;50(7):495-506
Prophylaxis and treatment of HIV-1 infection in pregnancy - Swedish Recommendations 2017
Naver L; Albert J; Carlander C; Flamholc L; Gisslen M; Karlstrom O; Svedhem-Johansson V; Sonnerborg A; Westling K; Yilmaz A; Pettersson K
Review: VIRUS RESEARCH. 2017;239:106-114
Error rates, PCR recombination, and sampling depth in HIV-1 whole genome deep sequencing
Zanini F; Brodin J; Albert J; Neher RA
Review: AIDS. 2017;31(9):1211-1222
Defining HIV-1 transmission clusters based on sequence data
Hassan AS; Pybus OG; Sanders EJ; Albert J; Esbjornsson J
Review: INFECTIOUS DISEASES. 2017;49(1):1-34
Antiretroviral treatment for HIV infection: Swedish recommendations 2016
Eriksen J; Albert J; Blaxhult A; Carlander C; Flamholc L; Gisslen M; Josephson F; Karlstrom O; Naver L; Svedhem V; Yilmaz A; Sonnerborg A
Review: INFECTIOUS DISEASES. 2016;48(2):93-98
Six-week follow-up after HIV-1 exposure: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Gaines H; Albert J; Axelsson M; Berglund T; Gisslen M; Sonnerborg A; Blaxhult A; Bogdanovic G; Brytting M; Carlander C; Flamholc L; Follin P; Haggar A; Hagstam P; Johansson M; Naver L; Blom JP; Samuelson A; Strom H; Sundqvist M; Johansson VS; Wisell KT; Tegnell A; Thorstensson R
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(10):673-677
Risk of HIV transmission from patients on antiretroviral therapy: A position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy
Albert J; Berglund T; Gisslen M; Groon P; Sonnerborg A; Tegnell A; Alexandersson A; Berggren I; Blaxhult A; Brytting M; Carlander C; Carlson J; Flamholc L; Follin P; Haggar A; Hansdotter F; Josephson F; Karlstrom O; Liljeros F; Naver L; Pettersson K; Johansson VS; Svennerholm B; Tunback P; Widgren K
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2014;46(6):401-411
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2013
Naver L; Albert J; Bottiger Y; Carlander C; Flamholc L; Gisslen M; Josephson F; Karlstrom O; Lindborg L; Svedhem-Johansson V; Svennerholm B; Sonnerborg A; Yilmaz A; Pettersson K
Editorial comment: JOURNAL OF INFECTIOUS DISEASES. 2012;205(2):163-165
Transmission of the X4 Phenotype of HIV-1: Is There Evidence Against the "Random Transmission" Hypothesis?
Hedskog C; Mild M; Albert J
Letter: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (1999). 2011;58(5):E135-E137
Estimates of HIV Transmitted Drug Resistance Can be Inflated Due to Natural Sequence Polymorphisms
Frentz D; van de Vijver DAMC; Boucher CAB; Albert J
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2011;270(6):502-508
Towards a world free from HIV and AIDS?
Albert J; Chiodi F
Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2011;1230:108-118
HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance
Skar H; Hedskog C; Albert J
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2011;43(6-7):411-423
Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010
Naver L; Albert J; Belfrage E; Flamholc L; Gisslen M; Gyllensten K; Josephson F; Karlstrom O; Lindgren S; Pettersson K; Svedhem V; Sonnerborg A; Westling K; Yilmaz A
Letter: NATURE. 2011;473(7347):284
Guidelines for HIV in court cases.
Leitner T
Review: THE LANCET INFECTIOUS DISEASES. 2011;11(5):394-407
European guidelines on the clinical management of HIV-1 tropism testing
Vandekerckhove LPR; Wensing AMJ; Kaiser R; Brun-Vezinet F; Clotet B; De Luca A; Dressler S; Garcia F; Geretti AM; Klimkait T; Korn K; Masquelier B; Perno CF; Schapiro JM; Soriano V; Sonnerborg A; Vandamme A-M; Verhofstede C; Walter H; Zazzi M; Boucher CAB; Puchhammer-Stockl E; Van Laethem K; Ivanov IA; Beshkov DA; Lepej SZ; Kostrikis LG; Linka M; Nielsen C; Zilmer K; Liitsola K; Braun P; Daeumer M; Obermeier M; Paraskevis D; Minarovits J; Coughlin S; de Gascun C; Grossman Z; Balotta C; Rusconi S; Svicher V; Kolupajeva T; Griskevicius A; Schmit J-CC; Schuurman R; Asjo B; Horban AJW; Camacho RJ; Ene L; Otelea D; Stanojevic M; Stanekova D; Poljak M; Paredes R; Poveda E; Albert J; Yerly S; Cane P; Pillay D
Letter: JOURNAL OF INFECTIOUS DISEASES. 2011;203(5):746
Reply to Redd et al
Nowroozalizadeh S; Mansson F; da Silva Z; Repits J; Pereira C; Biague A; Albert J; Fenyo EM; Norrgren H; Holmgren B; Jansson M
Editorial comment: THE LANCET INFECTIOUS DISEASES. 2011;11(2):78-79
Science in court: the myth of HIV fingerprinting
Abecasis AB; Geretti AM; Albert J; Power L; Weait M; Vandamme A-M
Corrigendum: NATURE. 2011;475(7354):37
Guidelines for HIV in court cases (vol 473, pg 284, 2011)
Leitner T
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2010;201(8):1150-1154
Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
Nowroozalizadeh S; Mansson F; da Silva Z; Repits J; Dabo B; Pereira C; Biague A; Albert J; Nielsen J; Aaby P; Fenyo EM; Norrgren H; Holmgren B; Jansson M
Editorial comment: AIDS. 2010;24(5):773-774
Can the further clinical development of bevirimat be justified?
Wainberg MA; Albert J
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(11-12):788-807
Treatment of HIV infection: Swedish recommendations 2009
Josephson F; Albert J; Flamholc L; Gisslen M; Karlstrom O; Moberg L; Naver L; Svedhem V; Svennerholm B; Sonnerborg A
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2008;40(6-7):451-461
Prophylaxis and treatment of HIV-1 infection in pregnancy:: Swedish recommendations 2007
Naver L; Bohlin A-B; Albert J; Flamholc L; Gisslen M; Gyllensten K; Josephson F; Pehrson P; Sonnerborg A; Westling K; Lindgren S
Editorial comment: JOURNAL OF INTERNAL MEDICINE. 2007;262(1):2-4
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines
Albert J; Chiodi F; Fenyo EM
Review: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2007;39(6-7):486-507
Antiretroviral treatment of HIV infection:: Swedish recommendations 2007
Josephson F; Albert J; Flamholc L; Gisslen M; Karlstroem O; Lindgren S-R; Navter L; Sandstroem E; Svedhem-Johansson V; Svennerholm B; Soennerborg A
Review: ANTIVIRAL THERAPY. 2004;9(6):829-848
Updated European recommendations for the clinical use of HIV drug resistance testing
Vandamme AM; Sönnerborg A; Ait-Khaled M; Albert J; Asjo B; Bacheler L; Banhegyi D; Boucher C; Brun-Vézinet F; Camacho R; Clevenbergh P; Clumeck N; Dedes N; De Luca A; Doerr HW; Faudon JL; Gatti G; Gerstoft J; Hall WW; Hatzakis A; Hellmann N; Horban A; Lundgren JD; Kempf D; Miller M; Miller V; Myers TW; Nielsen C; Opravil M; Palmisano L; Perno CF; Phillips A; Pillay D; Pumarola T; Ruiz L; Salminen M; Schapiro J; Schmidt B; Schmit JC; Schuurman R; Shulse E; Soriano V; Staszewski S; Vella S; Youle M; Ziermann R; Perrin L
Corrigendum: JOURNAL OF VIROLOGICAL METHODS. 2003;112(1-2):165
A simple and sensitive 'in-house' method for determining genotypic drug resistance in HIV-1 (vol 107, pg 45, 2003)
Lindström A; Albert J
Published conference paper: JOURNAL OF INFECTIOUS DISEASES. 2002;186(7):914-921
Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child
Casper CHE; Clevestig P; Carlenor E; Leitner T; Anzén B; Lidman K; Belfrage E; Albert J; Bohlin AB; Navér L; Lindgren S; Fenyö EM; Ehrnst AC
Corrigendum: JOURNAL OF VIROLOGY. 1998;72(3):2565
Tempo and mode of nucleotide substitution in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history (vol 71, pg 4761, 1997)
Leitner T; Kumar S; Albert J
Published conference paper: IMMUNOLOGY LETTERS. 1996;51(1-2):23-28
Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS
Scarlatti G; Leitner T; Hodara V; Jansson M; Karlsson A; Wahlberg J; Rossi P; Uhlen M; Fenyo EM; Albert J
Review: AIDS. 1996;10 Suppl A:S97-106
The role of the humoral immune response in HIV infection.
Fenyö EM; Albert J; McKeating J
Other: AIDS RESEARCH AND HUMAN RETROVIRUSES. 1995;11(8):995-997
YET ANOTHER SUBTYPE OF HIV TYPE-1
LEITNER T; ALAEUS A; MARQUINA S; LILJA E; LIDMAN K; ALBERT J
Letter: AIDS. 1995;9(7):822-823
BIOLOGICAL PHENOTYPE OF HIV-1 AND TRANSMISSION
ALBERT J; FIORE J; FENYO EM; PEDERSEN C; LUNDGREN JD; GERSTOFT J; NIELSEN C
Show more

Articles

All other publications

News from KI

Events from KI